A phase I study of ZD0473 and docetaxel given once every three weeks in patients with advanced refractory cancer. A National Cancer Institute of Canada-Clinical Trials Group Study (NCIC CTG-IND 131)
Year: 2001
Type: article
Source: European Journal of Cancer
Authors: K.A. Gelmon, D. Stewart, D. Ayers, D. Fry, L. Douglas, L.W. McIntosh, L.K. Seymour
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1991661175